T2 is seeking to fill an unmet need for Sepsis testing. Sepsis has been dramatically on the rise the past two decades killing many. The company has a date with the FDA closing in for its T2 Bacteria panel. If approved, the company would take a lead in the testing […]
Hello, your membership does not give you access to this page.